NFL playoff picture after Week 16: Ravens close in on AFC’s top seed; NFC up for grabs
Sports

NFL playoff picture after Week 16: Ravens close in on AFC’s top seed; NFC up for grabs

The Baltimore Ravens scored their most impressive victory of the season Monday night, defeating the San Francisco 49ers 33-19. Along with making them look like worthy Super Bowl contenders, the victory puts them in a fantastic position in the AFC. At 12-3, they’re a game ahead of Miami and have a chance to clinch the top spot next week in a game against those very Dolphins.Meanwhile, the 49ers’ loss sends them to 11-4 and a three-way tie atop the NFC with the Philadelphia Eagles and Detroit Lions. The 49ers own the tiebreaker over both, but with two games to go, there’s still time for the Eagles or Lions to make a move.As for the rest of the NFL, Week 16 saw plenty of movement in the playoff picture. Let’s take a look at where things stand as we enter Week 17.Listed odds to make the playof...
The First Secret Asteroid Mission Won’t Be the Last
Technology

The First Secret Asteroid Mission Won’t Be the Last

For generations, Western space missions have largely occurred out in the open. We knew where they were going, why they were going there and what they planned to do. But the world is on the verge of a new era in which private interests override such openness, with big money potentially on the line.Sometime in the coming year, a spacecraft from AstroForge, an American asteroid-mining firm, may be launched on a mission to a rocky object near Earth’s orbit. If successful, it will be the first wholly commercial deep-space mission beyond the moon. AstroForge, however, is keeping its target asteroid secret.The secret space-rock mission is the latest in an emerging trend that astronomers and other experts do not welcome: commercial space missions conducted covertly. Such missions highlight gaps in...
Downturn or Not? At Year’s End, Wall St. Is Split on What’s Ahead.
Business

Downturn or Not? At Year’s End, Wall St. Is Split on What’s Ahead.

Twelve months ago, Tom Lee bet that 2023 was going to turn out just fine.While many of his peers on Wall Street were sounding the alarm over an impending economic downturn, Mr. Lee, a stock market strategist who spent more than a decade running J.P. Morgan’s equity research before setting up his own firm, forecast in December 2022 that falling inflation and economic resilience would buck the broadly bearish mood.Mr. Lee was right. Despite political brinkmanship over the nation’s debt ceiling, a banking crisis in March, fears over the cost of funding the government’s fiscal deficit, a continuing war in Ukraine and fresh conflict in Israel, the core of Mr. Lee’s prediction came to fruition in 2023. Inflation has fallen, unemployment remains low, and the S&P 500 has risen 25 percent.Most ...
Brexiteers Vowed to ‘Take Back Control’ of U.K. Borders. What Happened?
World

Brexiteers Vowed to ‘Take Back Control’ of U.K. Borders. What Happened?

Inflammatory warnings from politicians. Knife-edge votes in Parliament. A looming election against a backdrop of national crisis. Britain’s ruling Conservative Party has been caught up in a clamorous debate over deporting asylum seekers to Rwanda, which has at times sounded like a not-so-distant echo of Brexit.Yet for all the fury it has generated, the Rwanda plan is little more than a sideshow in the surprising story of immigration in post-Brexit Britain. While refugees who make hazardous crossings of the English Channel in rickety boats pose a humanitarian challenge, they constitute a fraction — less than 5 percent — of the number of people who immigrate to the country legally every year.Far from closing its borders, Britain has thrown them open since voting in 2016 to leave the European...
Monica Bertagnolli, NIH’s New Leader, Wants to Broaden Participation in Medical Research
Health

Monica Bertagnolli, NIH’s New Leader, Wants to Broaden Participation in Medical Research

When Dr. Monica M. Bertagnolli moved into the director’s suite at the National Institutes of Health, she brought with her a single piece of art, a lithograph created by the granddaughter of a cancer patient she once treated. It depicts an abstract geometric female figure and the organs she lost to cancer. Its title: “We Are Not What You Have Taken: A Response to Cancer.”The image speaks to Dr. Bertagnolli, a cancer surgeon who previously led the National Cancer Institute and is a breast-cancer survivor herself.After being nominated by President Biden in the spring and winning Senate confirmation last month, she became the 17th director of the N.I.H., which has a budget of more than $47 billion and occupies a sprawling campus in Bethesda, Md. She is only the second woman to lead the biomedi...
Golf with a purpose: How The Park dared to be different
Sports

Golf with a purpose: How The Park dared to be different

WEST PALM BEACH, Fla. — It’s lunchtime on a mid-November Saturday afternoon and the word of the day is eclectic. I’ve just finished my morning round at The Park with a three-putt for par on the forgiving 18th hole, and I saddle up at the cabana, the bar/small bites stand strategically located at the front of the property.A foursome that was a few holes ahead of me is heading off to their vehicles — while allowing for their anonymity, let’s just say they can be members anywhere they want to be in the golf-rich West Palm Beach/Jupiter area. Making the turn to the back nine are the bros wanting to chase down their transfusions with High Noons. Though they represent very different ends of the Saturday golfer spectrum, you recognize both groups as what a golfer “looks” like.But the cabana occup...
This N.Y.U. Student Owns a $6 Million Crypto Mine. His Secret Is Out.
Technology

This N.Y.U. Student Owns a $6 Million Crypto Mine. His Secret Is Out.

Jerry Yu has the trappings of what the Chinese call second-generation rich. He boasts a Connecticut prep-school education. He lives in a Manhattan condominium bought for $8 million from Jeffrey R. Immelt, the former General Electric chief executive. And he is the majority owner of a Bitcoin mine in Texas, acquired last year for more than $6 million.Mr. Yu, a 23-year-old student at New York University, has also become — quite unintentionally — a case study in how Chinese nationals can move money from China to the United States without drawing the attention of authorities in either country.The Texas facility, a large computing center, was not purchased with dollars. Instead, it was bought with cryptocurrency, which offers anonymity, with the transaction routed through an offshore exchange, p...
Red Sea Shipping Halt Is Latest Risk to Global Economy
Business

Red Sea Shipping Halt Is Latest Risk to Global Economy

The attacks on crucial shipping traffic in the Red Sea straits by a determined band of militants in Yemen — a spillover from the Israeli-Hamas war in Gaza — are injecting a new dose of instability into a world economy already struggling with mounting geopolitical tensions.The risk of escalating conflict in the Middle East is the latest in a string of unpredictable crises, including the Covid-19 pandemic and the war in Ukraine, that have landed like swipes of a bear claw on the global economy, smacking it off course and leaving scars.As if that weren’t enough, more volatility lies ahead in the form of a wave of national elections whose repercussions could be deep and long. More than two billion people in roughly 50 countries, including India, Indonesia, Mexico, South Africa, the United Stat...
Bristol Myers to Acquire the Drugmaker Karuna for $14 Billion
Health

Bristol Myers to Acquire the Drugmaker Karuna for $14 Billion

Bristol Myers Squibb, the global pharmaceutical giant, said on Friday that it would acquire Karuna Therapeutics, which makes drugs to treat schizophrenia and Alzheimer’s, in an all-cash deal valued at $14 billion as it looks to strengthen its pipeline of neuroscience drugs.Bristol Myers said in a statement that it would pay $330 per share in cash, a premium of roughly 53 percent to Karuna’s share price on Thursday.An increasing prevalence of schizophrenia, driven in part by an aging population, has led to a push to make more drugs to treat it. The market for such therapies is estimated to grow to $12.6 billion by 2032, according to the research firm Market.Us. Earlier this month, the biomedical company AbbVie bought Cerevel Therapeutics, which develops drugs to treat psychiatric and neurol...